ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STX Shield Therapeutics Plc

2.15
0.15 (7.50%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 7.50% 2.15 2.10 2.20 2.15 2.00 2.00 2,572,354 10:18:35
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.41 16.67M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £16.67 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.41.

Shield Therapeutics Share Discussion Threads

Showing 9176 to 9199 of 23375 messages
Chat Pages: Latest  371  370  369  368  367  366  365  364  363  362  361  360  Older
DateSubjectAuthorDiscuss
29/6/2021
12:26
If a product is proven and has distinct advantages over the competitor product as Accrufer does, then its just a question of employing a sufficient number of incentivised competent salesmen and the product will sell. The new CEO seems to know what he is doing and understands the market, should be a cake walk for him, there are no complex problems or difficult hurdles to overcome.
rogerrail
29/6/2021
12:09
Love words like 'huge growth' :)
zeus19
29/6/2021
12:07
Thanks dent, wouldn`t be surprised to see an update from funky finance soon either.
dandu69
29/6/2021
11:40
hxxps://www.business-live.co.uk/enterprise/shield-therapeutic-shares-rise-launch-20889087
dent12
29/6/2021
10:49
Sorry wrong way round buys as sells. Ooops
little minx
29/6/2021
10:45
As already discussed algorithms shows sells as buy so giving a nice distorted image.
little minx
29/6/2021
09:47
Yes, and then it might rise up to 50p !!!
daveboy19
29/6/2021
09:33
With a bit of luck at the end of September we might get a quarterly update on the first sales!!..
cyberbub
28/6/2021
19:00
A FUNKY SHARE...
just keep buying the dips and hold for 10 yrs

transhoneyqueens
28/6/2021
17:23
Friskymickey....the way I look at it is very simple. Except for those with intolerance or other reasons that they cannot take Accrufer, all the patients with IDS will have a choice. Spend more and all the time, discomfort etc and have IV or take Accrufer.

Now I really hate the expression...it's a no brainer....but sometimes it is relevant. OK there will be some months of uncertainty but I look at the logic always. What would you do in this decision process given you MUST have one.

Buy. Hold. Forget. Wake up in two years and go nice.

purchaseatthetop
28/6/2021
15:47
Thanks PATT, with product on sale from Thursday and i liked the spread so could not resist.
friskymickey
28/6/2021
15:40
Forget about the price UNLESS you do a great value add like friskymickey...good call
purchaseatthetop
28/6/2021
15:16
Just topped up at 52.38p :)
friskymickey
28/6/2021
10:42
Just forget about the share price for the next months. Makes no difference to the price in three years. If Greg delivers which I am sure he will it might be around 250p. What it does now is determined by nervous Nigel from Bermondsey who wants to buy EEE cos Twitter tells him to so sells STX because he cannot miss out.
purchaseatthetop
28/6/2021
10:37
Yes the share price is being very controlled imho
little minx
28/6/2021
10:31
Dropping it on very low volume again. Same as last week.
eastlands
28/6/2021
10:21
So you know the exact plan of the new CEO inside out?Then please enlighten us with your inside knowledge.
little minx
28/6/2021
10:20
So you know the new
little minx
28/6/2021
10:12
Kodak made billions selling their rolls of film invented by Eastman
In 1975 one of their employees invented the digital camara.
They sat on the patent for years and did nothing because they worried that it would undermine their film business,eventually a competitor started selling digital cameras Kodak licensed the patents out and did nothing .In three years they went bust
We see the benefit to the patients of the pill over the infusion but the existing players, they only see this as a threat to their infusion business.
Our marketing people are going to get absolutely nowhere by approaching big infusion providers.
They need to think just a little outside of the box.
My Nickname is very appropriate .I am a disrupter not a follower.
There is a way to make billions from our iron deficiency treatment but it’s not this way.

baddogrex1
25/6/2021
20:47
PerformanceThe Group closed 2020 with £2.9 million cash but has since raised £29.2 million gross proceeds from a fundraise completed in March 2021.
oapknob1
25/6/2021
20:42
Why you reckon they've spent this since 26th February 2021 then.Shield Therapeutics PLC Successful completion of GBP25 million Fundraise
oapknob1
25/6/2021
19:04
maybe we will need additional funding next month ?
jackson83
25/6/2021
17:18
Friskymickey...not really. We have our logic but do not see how many are wanting to sell with the news. Delighted with this week. 60p will come sooner rather than later and then be left in the dust. Even those who bought on the news at 58p and got spiked will be fine soon.

It is the way it is.

purchaseatthetop
25/6/2021
15:52
60p by end of the week lmao ramp ramp ramp....
friskymickey
Chat Pages: Latest  371  370  369  368  367  366  365  364  363  362  361  360  Older